Physician profile
Troy L Hounshell
NPI 1730387473
$163,914.45
in general payments reported to CMS, 2019-2025
17 companies · $49K in 2025
The $49K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $12K · 2021: $8,931 · 2022: $18K · 2023: $16K · 2024: $38K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $49K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Food and Beverage: $7,991 · Travel and Lodging: $7,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,937.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,250.00 |
| Food and Beverage | $7,990.63 |
| Travel and Lodging | $7,710.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $119,575.73 | 2019-2025 | Farapulse, Watchman Access System, Watchman |
| Medtronic, INC. | $17,623.32 | 2021-2025 | Linq II, Arctic Front Advance, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $12,614.64 | 2019-2025 | Aveir, Ensite, Amplatzer Amulet |
| Medtronic Vascular, INC. | $11,510.08 | 2019-2020 | |
| Atricure, INC. | $1,377.48 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $189.01 | 2020-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Impulse Dynamics (USA) INC. | $188.13 | 2023 | Optimizer |
| Volta Medical INC | $175.72 | 2024 | Vx1 |
| Novartis Pharmaceuticals Corporation | $126.96 | 2023-2025 | |
| Inspire Medical Systems, INC. | $112.39 | 2024 | Inspire |
| Biosense Webster, INC. | $110.39 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $87.78 | 2022-2025 | Camzyos |
| Pfizer INC. | $64.63 | 2025 | |
| Heartflow, INC. | $61.39 | 2025 | |
| Edwards Lifesciences Corporation | $57.74 | 2022-2024 | Hemosphere |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $19.95 | 2024 | |
| Teleflex LLC | $19.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Hounshell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.